Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Secreted, extracellular space, extracellular matrix. |
Domain |
PF13855 Leucine rich repeat PF00093 von Willebrand factor type C domain |
Function |
Promotes matrix assembly and cell adhesiveness. |
Biological Process |
GO:0007160 cell-matrix adhesion GO:0007409 axonogenesis GO:0010810 regulation of cell-substrate adhesion GO:0010811 positive regulation of cell-substrate adhesion GO:0030198 extracellular matrix organization GO:0031589 cell-substrate adhesion GO:0043062 extracellular structure organization GO:0045785 positive regulation of cell adhesion GO:0048667 cell morphogenesis involved in neuron differentiation GO:0061564 axon development |
Molecular Function |
GO:0005178 integrin binding GO:0005518 collagen binding GO:0005539 glycosaminoglycan binding GO:0008201 heparin binding GO:0050839 cell adhesion molecule binding GO:0070052 collagen V binding GO:1901681 sulfur compound binding |
Cellular Component |
GO:0005578 proteinaceous extracellular matrix GO:0005614 interstitial matrix |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between ECM2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of ECM2 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of ECM2 in various data sets.
|
Points in the above scatter plot represent the mutation difference of ECM2 in various data sets.
|
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of ECM2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of ECM2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by ECM2. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of ECM2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of ECM2 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between ECM2 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | ECM2 |
Name | extracellular matrix protein 2, female organ and adipocyte specific |
Aliases | matrix glycoprotein SC1/ECM2; Extracellular matrix protein 2 |
Chromosomal Location | 9q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting ECM2 collected from DrugBank database. |
There is no record. |